Literature DB >> 18326691

Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD.

Majda Hadziahmetovic1, Tzvete Dentchev, Ying Song, Nadine Haddad, Xining He, Paul Hahn, Domenico Pratico, Rong Wen, Z Leah Harris, John D Lambris, John Beard, Joshua L Dunaief.   

Abstract

PURPOSE: Iron is an essential element in human metabolism but also is a potent generator of oxidative damage with levels that increase with age. Several studies suggest that iron accumulation may be a factor in age-related macular degeneration (AMD). In prior studies, both iron overload and features of AMD were identified in mice deficient in the ferroxidase ceruloplasmin (Cp) and its homologue hephaestin (Heph) (double knockout, DKO). In this study, the location and timing of iron accumulation, the rate and reproducibility of retinal degeneration, and the roles of oxidative stress and complement activation were determined.
METHODS: Morphologic analysis and histochemical iron detection by Perls' staining was performed on retina sections from DKO and control mice. Immunofluorescence and immunohistochemistry were performed with antibodies detecting activated complement factor C3, transferrin receptor, L-ferritin, and macrophages. Tissue iron levels were measured by atomic absorption spectrophotometry. Isoprostane F2alpha-VI, a specific marker of oxidative stress, was quantified in the tissue by gas chromatography/mass spectrometry.
RESULTS: DKOs exhibited highly reproducible age-dependent iron overload, which plateaued at 6 months of age, with subsequent progressive retinal degeneration continuing to at least 12 months. The degeneration shared some features of AMD, including RPE hypertrophy and hyperplasia, photoreceptor degeneration, subretinal neovascularization, RPE lipofuscin accumulation, oxidative stress, and complement activation.
CONCLUSIONS: DKOs have age-dependent iron accumulation followed by retinal degeneration modeling some of the morphologic and molecular features of AMD. Therefore, these mice are a good platform on which to test therapeutic agents for AMD, such as antioxidants, iron chelators, and antiangiogenic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326691      PMCID: PMC2569891          DOI: 10.1167/iovs.07-1472

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  A potential role for immune complex pathogenesis in drusen formation.

Authors:  L V Johnson; S Ozaki; M K Staples; P A Erickson; D H Anderson
Journal:  Exp Eye Res       Date:  2000-04       Impact factor: 3.467

Review 2.  An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.

Authors:  G S Hageman; P J Luthert; N H Victor Chong; L V Johnson; D H Anderson; R F Mullins
Journal:  Prog Retin Eye Res       Date:  2001-11       Impact factor: 21.198

3.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

4.  Synthesis and secretion of transferrin by isolated ciliary epithelium of rabbit.

Authors:  Rubens Bertazolli-Filho; Eduardo Miguel Laicine; Antonio Haddad
Journal:  Biochem Biophys Res Commun       Date:  2003-06-13       Impact factor: 3.575

Review 5.  New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland.

Authors:  Miguel Coca-Prados; Julio Escribano
Journal:  Prog Retin Eye Res       Date:  2007-01-17       Impact factor: 21.198

6.  Transferrin receptor-mediated gene transfer to the corneal endothelium.

Authors:  P H Tan; W J King; D Chen; H M Awad; M Mackett; R I Lechler; D F Larkin; A J George
Journal:  Transplantation       Date:  2001-02-27       Impact factor: 4.939

Review 7.  The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.

Authors:  George Perry; Lawrence M Sayre; Craig S Atwood; Rudolph J Castellani; Adam D Cash; Catherine A Rottkamp; Mark A Smith
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  The role of apoptosis in age-related macular degeneration.

Authors:  Joshua L Dunaief; Tzvete Dentchev; Gui-Shuang Ying; Ann H Milam
Journal:  Arch Ophthalmol       Date:  2002-11

Review 9.  A role for local inflammation in the formation of drusen in the aging eye.

Authors:  Don H Anderson; Robert F Mullins; Gregory S Hageman; Lincoln V Johnson
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

10.  Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains.

Authors:  Hiroaki Miyajima; Satoshi Kono; Yoshitomo Takahashi; Masahiro Sugimoto
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

View more
  65 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 2.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 3.  Iron, the retina and the lens: a focused review.

Authors:  Sixto García-Castiñeiras
Journal:  Exp Eye Res       Date:  2010-03-15       Impact factor: 3.467

4.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

5.  Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.

Authors:  Manas R Biswal; Chulbul M Ahmed; Cristhian J Ildefonso; Pingyang Han; Hong Li; Hiral Jivanji; Haoyu Mao; Alfred S Lewin
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

Review 6.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

7.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

8.  SPECKLED HYPOAUTOFLUORESCENCE AS A SIGN OF RESOLVED SUBRETINAL HEMORRHAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  S Amal Hussnain; Rosa Dolz-Marco; Joshua L Dunaief; Christine A Curcio; K Bailey Freund
Journal:  Retina       Date:  2019-10       Impact factor: 4.256

9.  AMD-like retinopathy associated with intravenous iron.

Authors:  Delu Song; Levi N Kanu; Yafeng Li; Kristen L Kelly; Rupak K Bhuyan; Tomas Aleman; Jessica I W Morgan; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2016-08-23       Impact factor: 3.467

10.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

Authors:  Nina Lukinova; Jared Iacovelli; Tzvete Dentchev; Natalie Wolkow; Allan Hunter; Defne Amado; Gui-Shuang Ying; Janet R Sparrow; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.